University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

Hospital


Location: Leuven, Belgium (BE) BE

ISNI: 0000000406263338

ROR: https://ror.org/0424bsv16

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025 (2025) Dinis-Ribeiro M, Libânio D, Uchima H, Spaander MC, Bornschein J, Matysiak-Budnik T, Tziatzios G, et al. Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article Combined Pancreas-Kidney Transplantation After Rescue Allocation: The Eurotransplant Experience: A Retrospective Multicenter Outcome Analysis (2025) Assfalg V, Stocker F, Hüser N, Hartmann D, Matevossian E, van Bruchem M, Vogelaar S, et al. Journal article Biological and mechanical challenges in the endodontic treatment of immature teeth with pulp necrosis: insights based on a Series of Atypical Clinical Cases (2025) Leprince JG, Okamoto M, Widbiller M, Beauquis J, Pedano SM, Galler KM, Takahashi Y Journal article A Consensus Statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research (2025) Metwaly A, Kriaa A, Hassani Z, Carraturo F, Druart C, Pinto F, Asnicar F, et al. Journal article Towards Automated Multi-regional Lung Parcellation for 0.55-3T 3D T2w Fetal MRI (2025) Uus AU, Zampieri CA, Downes F, Collado AE, Hall M, Davidson J, Payette K, et al. Conference contribution Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum Hodgkin lymphoma: hypodense lesions in mediastinal masses (2024) Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A, Cepelova M, Ceppi F, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article